Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
JXSL2000211 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(1) | Import Drug Application | 2020-12-14 | AstraZeneca AB | AstraZeneca AB | In Review | 2020-12-03 | view |
JXHL1500188 | AZD9291 | osimertinib mesylate | Other | Chemical Drugs | Import Drug Application | 2015-07-23 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2016-05-05 | view |
JXHL1400178 | AZD9291 | osimertinib mesylate | Other | Chemical Drugs | Import Drug Application | 2014-06-03 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2015-07-27 | view |
JXHL1500194 | AZD9291 | osimertinib mesylate | Other | Chemical Drugs | Import Drug Application | 2015-08-12 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2016-05-20 | view |
JXHL1400293 | AZD9291 | osimertinib mesylate | Other | Chemical Drugs | Import Drug Application | 2014-09-01 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2015-11-26 | view |
JXHL1400204 | AZD9291 | osimertinib mesylate | Other | Chemical Drugs | Import Drug Application | 2014-06-27 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2015-07-27 | view |
JXHL1500193 | AZD9291 | osimertinib mesylate | Other | Chemical Drugs | Import Drug Application | 2015-08-12 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2016-05-20 | view |
JXHL1400205 | AZD9291 | osimertinib mesylate | Other | Chemical Drugs | Import Drug Application | 2014-06-20 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2015-07-27 | view |
JXHL1400292 | AZD9291 | osimertinib mesylate | Other | Chemical Drugs | Import Drug Application | 2014-09-11 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2015-11-26 | view |
JXHL1500189 | AZD9291 | osimertinib mesylate | Other | Chemical Drugs | Import Drug Application | 2015-07-23 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2016-05-05 | view |
JXHL1400177 | AZD9291 | osimertinib mesylate | Other | Chemical Drugs | Import Drug Application | 2014-06-09 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2015-07-27 | view |
JXSL2100018 | Benralizumab注射液 | benralizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-02-05 | AstraZeneca AB | AstraZeneca AB | In Review | 2021-02-05 | view |
JXSL2000188 | Benralizumab注射液 | benralizumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-10-27 | AstraZeneca AB | AstraZeneca AB | In Review | 2020-10-23 | view |
JXSL1900123 | Benralizumab注射液 | benralizumab | Injection | Biological Products | Import Drug Application | 2019-11-27 | AstraZeneca AB | AstraZeneca AB | In Review | 2019-11-26 | view |
JYSB2100093 | Benralizumab注射液 | benralizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-04-08 | AstraZeneca AB | AstraZeneca AB | In Review | 2021-04-07 | view |
JXHL1100492 | Fostamatinib片 | fostamatinib disodium | Tablet | Chemical Drugs | Import Drug Application | 2012-01-11 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2013-09-24 | view |
JXHL1100493 | Fostamatinib片 | fostamatinib disodium | Tablet | Chemical Drugs | Import Drug Application | 2011-12-30 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2013-09-24 | view |
JXSL2000141 | Nirsevimab注射液 | nirsevimab | Injection | Biological Products(1) | Import Drug Application | 2020-08-05 | AstraZeneca AB | AstraZeneca AB | In Review | 2020-08-04 | view |
JXHL1300493 | Olaparib | olaparib | Active ingredient | Chemical Drugs | Import Drug Application | 2013-12-26 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2014-11-13 | view |
JXHL1300398 | Olaparib | olaparib | Active ingredient | Chemical Drugs | Import Drug Application | 2013-10-10 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2014-09-25 | view |